MHC Class II HLA-DP/DQ/DR anticorps (FITC)

N° du produit ABIN305021

L’anticorps anti-MHC Class II HLA-DP/DQ/DR Monoclonal Souris est utilisé pour la détection de MHC Class II HLA-DP/DQ/DR dans des échantillons de Humain. Il a été validé pour FACS.

Aperçu rapide pour MHC Class II HLA-DP/DQ/DR anticorps (FITC) (ABIN305021)

Antigène: MHC Class II HLA-DP/DQ/DR (HLA-DP/DQ/DR)

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp MHC Class II HLA-DP/DQ/DR est conjugé à/à la FITC

Application: Flow Cytometry (FACS)

Clone: Bu26

Détail du produit anti-MHC Class II HLA-DP/DQ/DR anticorps (FITC)

Specificité: Recognizes the beta chains of class II human major histocompatibility (MHC) antigens. The Reacts with DP, DQ, DR beta chains, which are expressed by antigen presenting cells, B- cells, monocytes and activated T lymphocytes. MHC class II molecules play a central role in the immune system by presenting peptides derived from extracellular proteins.

Purification: Affinity purified

Immunogène:

Type of Immunogen: Native protein

Isotype: IgG1

Information d'application

Indications d'application: Approved: Flo (1:1 - 1:10)

Usage: Flow Cytometry: Use 10 μL of the suggested working dilution to label 1x10^6 cells in 100 μL. Method sheets are available on request. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS, 0.09 % sodium azide, 1 % BSA.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.

Détails sur MHC Class II HLA-DP/DQ/DR

Antigène: MHC Class II HLA-DP/DQ/DR (HLA-DP/DQ/DR)

Autre désignation: HLA-DP+DQ+DR

Sujet: This antibody detects: HLA-DP+DQ+DR

Pathways: Human Leukocyte Antigen (HLA) in Adaptive Immune Response